NY-ESO-1–specific TCR–engineered T cells mediate sustained antigen-specific antitumor effects in myeloma
University of Maryland, Baltimore · University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center · +4 more institutions
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
844
total citations
- FWCI
- 38.09
- Percentile
- 100%
- References
- 67
Citations per year
Authors
35- APAaron P. RapoportCorresponding
University of Maryland, Baltimore, University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center
- EAEdward A. Stadtmauer
University of Pennsylvania
- GBGwendolyn Binder-Scholl
Adaptimmune (United Kingdom)
- OGOlga Goloubeva
University of Maryland, Baltimore, University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center
- DTDan T. Vogl
University of Pennsylvania
Topics & keywords
Topics
Keywords
- Cytotoxic T cell
- Antigen
- Medicine
- Multiple myeloma
- Immunology
- T-cell receptor
- Chimeric antigen receptor
- Cancer research
UN Sustainable Development Goals
- Good health and well-being
No related works found for this paper.